Company · CIK 0001411158
Anacor Pharmaceuticals, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SC 13G/AAnacor Pharmaceuticals, Inc.0001144204-16-112431 · 84.0 KBSEC(opens sec.gov)
- SC 13G/AAnacor Pharmaceuticals, Inc.0000315066-16-006001 · 8.5 KBSEC(opens sec.gov)
- 4Insider trades0000950103-16-014342 · 20.0 KBSEC(opens sec.gov)
- 4Insider trades0000950103-16-014340 · 11.9 KBSEC(opens sec.gov)
- 4Insider trades0000950103-16-014339 · 9.4 KBSEC(opens sec.gov)
- 4Insider trades0000950103-16-014338 · 19.4 KBSEC(opens sec.gov)
- 4Insider trades0000950103-16-014337 · 9.8 KBSEC(opens sec.gov)
- 4Insider trades0000950103-16-014336 · 9.9 KBSEC(opens sec.gov)
- 4Insider trades0000950103-16-014335 · 29.2 KBSEC(opens sec.gov)
- 4Insider trades0000950103-16-014334 · 16.4 KBSEC(opens sec.gov)
Insiders
- Bell GraemeExecutive VP and CFO
- BERNS PAUL LDirector, President and CEO
- CARE CAPITAL INVESTMENTS II LP10% Owner
- Chanda SanjaySVP, Drug Development
- GSK plc10% Owner
- Heyman Irwin ASenior VP, Drug Development
- Hong ZhiDirector
- Hove Anders DDirector
- IPPOLITO VINCENT PEVP & Chief Commercial Officer
- KAIROUZ HABIB10% Owner
Tickers
No tickers on record.
Addresses
business
1020 E. MEADOW CIRCLE
PALO ALTO, CA, 94303
mailing
1020 E. MEADOW CIRCLE
PALO ALTO, CA, 94303
Former names
- Anacor Pharmaceuticals Inc2013-04-08
Same industry